(LEN) Lennar - Overview
Sector: Consumer Cyclical | Industry: Residential Construction | Exchange: NYSE (USA) | Market Cap: 20.443m USD | Total Return: -14% in 12m
Avg Turnover: 215M
EPS Trend: -78.0%
Qual. Beats: 0
Rev. Trend: 6.0%
Qual. Beats: -1
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Lennar Corporation (NYSE: LEN) is a diversified real estate company and one of the largest homebuilders in the United States. Founded in 1954 and headquartered in Miami, the firm constructs single-family attached and detached homes across several geographic segments, including the East, Central, South Central, and West regions. Its business model targets a broad demographic spectrum ranging from first-time buyers to luxury and active adult markets.
The company operates an integrated service model that includes mortgage financing, title insurance, and closing services, which helps capture additional revenue throughout the home-buying lifecycle. Beyond residential sales, Lennar develops and manages multifamily rental properties and engages in land development and investment fund activities. The homebuilding sector is highly sensitive to interest rate fluctuations and labor costs, which directly impact construction margins and buyer affordability.
To gain a deeper understanding of the companys valuation metrics, you may find it useful to explore more data on ValueRay. Lennar’s scale allows it to leverage significant purchasing power with suppliers, a common competitive advantage for top-tier national builders in a fragmented industry.
- Mortgage rate fluctuations directly impact new home demand and buyer affordability
- Strategic land-light model transition improves capital efficiency and free cash flow
- Rising construction labor and material costs pressure homebuilding gross margins
- Financial services segment profitability relies on mortgage origination volume and spreads
- Housing inventory shortage in core markets sustains elevated average selling prices
| Net Income: 1.79b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -4.51 > 1.0 |
| NWC/Revenue: 29.90% < 20% (prev 35.84%; Δ -5.94% < -1%) |
| CFO/TA 0.01 > 3% & CFO 177.4m > Net Income 1.79b |
| Net Debt (3.33b) to EBITDA (2.33b): 1.43 < 3 |
| Current Ratio: 3.74 > 1.5 & < 3 |
| Outstanding Shares: last quarter (244.4m) vs 12m ago -6.96% < -2% |
| Gross Margin: 16.77% > 18% (prev 0.22%; Δ 1.66k% > 0.5%) |
| Asset Turnover: 97.18% > 50% (prev 102.3%; Δ -5.17% > 0%) |
| Interest Coverage Ratio: 9.85 > 6 (EBITDA TTM 2.33b / Interest Expense TTM 222.2m) |
| A: 0.30 (Total Current Assets 13.5b - Total Current Liabilities 3.61b) / Total Assets 33.2b |
| B: 0.68 (Retained Earnings 22.6b / Total Assets 33.2b) |
| C: 0.06 (EBIT TTM 2.19b / Avg Total Assets 34.1b) |
| D: 2.02 (Book Value of Equity 22.6b / Total Liabilities 11.2b) |
| Altman-Z'' = 6.73 = AAA |
| DSRI: 0.68 (Receivables 960.9m/1.53b, Revenue 33.1b/35.8b) |
| GMI: 1.31 (GM 16.77% / 21.95%) |
| AQI: 0.83 (AQ_t 0.39 / AQ_t-1 0.47) |
| SGI: 0.93 (Revenue 33.1b / 35.8b) |
| TATA: 0.05 (NI 1.79b - CFO 177.4m) / TA 33.2b) |
| Beneish M = -3.12 (Cap -4..+1) = AA |
As of May 24, 2026, the stock is trading at USD 88.83 with a total of 2,489,564 shares traded.
Over the past week, the price has changed by +7.97%,
over one month by -5.65%,
over three months by -23.12% and
over the past year by -13.95%.
Lennar has received a consensus analysts rating of 3.48. Therefore, it is recommended to hold LEN.
- StrongBuy: 4
- Buy: 2
- Hold: 15
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 91.5 | 3% |
P/E Forward = 14.4092
P/S = 0.6162
P/B = 0.9949
P/EG = 0.7432
Revenue TTM = 33.1b USD
EBIT TTM = 2.19b USD
EBITDA TTM = 2.33b USD
Long Term Debt = 5.26b USD (from longTermDebt, last quarter)
Short Term Debt = 429.0m USD (from shortTermDebt, last quarter)
Debt = 5.69b USD (corrected: LT Debt 5.26b + ST Debt 429.0m)
Net Debt = 3.33b USD (calculated: Debt 5.69b - CCE 2.35b)
Enterprise Value = 23.8b USD (20.4b + Debt 5.69b - CCE 2.35b)
Interest Coverage Ratio = 9.85 (Ebit TTM 2.19b / Interest Expense TTM 222.2m)
EV/FCF = 1000.0x (Enterprise Value 23.8b / FCF TTM 14.8m)
FCF Yield = 0.06% (FCF TTM 14.8m / Enterprise Value 23.8b)
FCF Margin = 0.04% (FCF TTM 14.8m / Revenue TTM 33.1b)
Net Margin = 5.40% (Net Income TTM 1.79b / Revenue TTM 33.1b)
Gross Margin = 16.77% ((Revenue TTM 33.1b - Cost of Revenue TTM 27.6b) / Revenue TTM)
Gross Margin QoQ = 15.23% (prev 16.29%)
Tobins Q-Ratio = 0.72 (Enterprise Value 23.8b / Total Assets 33.2b)
Interest Expense / Debt = 3.91% (Interest Expense 222.2m / Debt 5.69b)
Taxrate = 22.84% (69.1m / 302.5m)
NOPAT = 1.69b (EBIT 2.19b * (1 - 22.84%))
Current Ratio = 3.74 (Total Current Assets 13.5b / Total Current Liabilities 3.61b)
Debt / Equity = 0.26 (Debt 5.69b / totalStockholderEquity, last quarter 21.9b)
Debt / EBITDA = 1.43 (Net Debt 3.33b / EBITDA 2.33b)
Debt / FCF = 225.6 (Net Debt 3.33b / FCF TTM 14.8m)
Total Stockholder Equity = 22.2b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.24% (Net Income 1.79b / Total Assets 33.2b)
RoE = 8.04% (Net Income TTM 1.79b / Total Stockholder Equity 22.2b)
RoCE = 7.96% (EBIT 2.19b / Capital Employed (Equity 22.2b + L.T.Debt 5.26b))
RoIC = 5.63% (NOPAT 1.69b / Invested Capital 30.0b)
WACC = 7.71% (E(20.4b)/V(26.1b) * Re(9.01%) + D(5.69b)/V(26.1b) * Rd(3.91%) * (1-Tc(0.23)))
Discount Rate = 9.01% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -100.00 | Cagr: -5.77%
[DCF] Terminal Value 73.10% ; FCFF base≈645.6m ; Y1≈566.2m ; Y5≈457.4m
[DCF] Fair Price = 18.63 (EV 7.34b - Net Debt 3.33b = Equity 4.01b / Shares 215.2m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -78.03 | EPS CAGR: -20.20% | SUE: -0.24 | # QB: 0
Revenue Correlation: 6.02 | Revenue CAGR: 0.20% | SUE: -1.51 | # QB: -1
EPS current Quarter (2026-05-31): EPS=1.25 | Chg30d=-11.56% | Revisions=-54% | Analysts=10
EPS next Quarter (2026-08-31): EPS=1.75 | Chg30d=-7.83% | Revisions=-50% | Analysts=10
EPS current Year (2026-11-30): EPS=6.04 | Chg30d=-0.72% | Revisions=-43% | GrowthEPS=-25.1% | GrowthRev=-3.2%
EPS next Year (2027-11-30): EPS=7.59 | Chg30d=-1.85% | Revisions=-33% | GrowthEPS=+25.7% | GrowthRev=+6.3%
[Analyst] Revisions Ratio: -54%